A window into the body Ontario widens access to cancer drugsA high profile case of a woman who was denied coverage of Herceptin to treat her breast cancer tumour because it was “too small” seems to have inspired the Ontario government to expand patients’ access to cancer drugs. Acne gel, vaginosis tablets enter market Beware of patients bearing pamphlets Waiting room literature: pleasant diversion or lightning rod for inane questions? Catch-up clinics improve HPV vaccination rates Parents sometimes change their minds about having daughters immunized, Toronto researchers find FP-provided end-of-life care assessed in ongoing study In Nova Scotia, about one-third of patients get home visit, but only 18% receive info about symptom management Nonmelanoma skin cancers on rise in U.S. The incidence of nonmelanoma skin cancers—mainly basal cell and squamous cell carcinomas—continues to rise in the U.S., researchers reported here. Students miss melanomas in simulated tests Medical trainees need more preparation for real-life situations, researchers urge Successful treatment of nail psoriasis has beneficial side-effects Improvements in psoriasis of the hands and feet also observed when nails treated with adalimumab Triple Negative Breast Cancer Sensitive to Chemo Lower 10-year survival than other forms of breast CA Multaq (dronedarone) liver injury Sanofi-aventis and Health Canada are notifying healthcare professionals about the potential for serious liver injury with Multaq (dronedarone), including rare cases of hepatic failure. Mylan: important product recall First Previous 1775 1776 1777 1778 1779 Next Last
